Apeloa Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Apeloa Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.18 Million ≈ $65.29 Million USD) by net assets (CN¥6.35 Billion ≈ $928.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Apeloa Pharmaceutical Co Ltd (1998–2025)
Cash flow conversion efficiency of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. This chart illustrates how Apeloa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Apeloa Pharmaceutical Co Ltd (000739) share price today for real-time trading data and today's change.
Apeloa Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Apeloa Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Apeloa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apeloa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Apeloa Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Paramount Resources Ltd.
TO:POU
|
0.016x |
|
EASYJET PLC SP.ADR NEW/4
F:EJTS
|
N/A |
|
Strauss Group
TA:STRS
|
0.114x |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
0.089x |
|
Bullish
NYSE:BLSH
|
0.029x |
|
Incitec Pivot Ltd
AU:IPL
|
0.064x |
|
KINGS.CLOUD HLD.SP.ADR/15
F:KS7
|
0.321x |
|
Tsingtao Brewery Company Limited
F:TSI
|
0.086x |
Annual Cash Flow Conversion Efficiency for Apeloa Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. Review Apeloa Pharmaceutical Co Ltd (000739) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.35 Billion ≈ $928.67 Million |
CN¥1.23 Billion ≈ $180.09 Million |
0.194x | +8.29% |
| 2024-12-31 | CN¥6.75 Billion ≈ $987.72 Million |
CN¥1.21 Billion ≈ $176.88 Million |
0.179x | +8.18% |
| 2023-12-31 | CN¥6.23 Billion ≈ $911.71 Million |
CN¥1.03 Billion ≈ $150.92 Million |
0.166x | -31.10% |
| 2022-12-31 | CN¥5.52 Billion ≈ $807.64 Million |
CN¥1.33 Billion ≈ $194.05 Million |
0.240x | +98.74% |
| 2021-12-31 | CN¥5.06 Billion ≈ $740.44 Million |
CN¥611.75 Million ≈ $89.52 Million |
0.121x | -49.90% |
| 2020-12-31 | CN¥4.39 Billion ≈ $642.49 Million |
CN¥1.06 Billion ≈ $155.04 Million |
0.241x | -33.15% |
| 2019-12-31 | CN¥3.77 Billion ≈ $551.37 Million |
CN¥1.36 Billion ≈ $199.02 Million |
0.361x | +45.01% |
| 2018-12-31 | CN¥3.35 Billion ≈ $489.52 Million |
CN¥832.69 Million ≈ $121.85 Million |
0.249x | +261.87% |
| 2017-12-31 | CN¥3.05 Billion ≈ $446.31 Million |
CN¥209.80 Million ≈ $30.70 Million |
0.069x | -0.24% |
| 2016-12-31 | CN¥2.62 Billion ≈ $382.88 Million |
CN¥180.42 Million ≈ $26.40 Million |
0.069x | -62.22% |
| 2015-12-31 | CN¥2.42 Billion ≈ $353.65 Million |
CN¥441.16 Million ≈ $64.56 Million |
0.183x | -46.49% |
| 2014-12-31 | CN¥2.31 Billion ≈ $337.43 Million |
CN¥786.64 Million ≈ $115.11 Million |
0.341x | +232.78% |
| 2013-12-31 | CN¥1.86 Billion ≈ $271.86 Million |
CN¥190.45 Million ≈ $27.87 Million |
0.103x | -58.33% |
| 2012-12-31 | CN¥1.37 Billion ≈ $199.83 Million |
CN¥335.90 Million ≈ $49.15 Million |
0.246x | -25.14% |
| 2011-12-31 | CN¥1.23 Billion ≈ $180.21 Million |
CN¥404.62 Million ≈ $59.21 Million |
0.329x | +119.48% |
| 2010-12-31 | CN¥808.57 Million ≈ $118.32 Million |
CN¥121.05 Million ≈ $17.71 Million |
0.150x | -42.88% |
| 2009-12-31 | CN¥794.78 Million ≈ $116.30 Million |
CN¥208.30 Million ≈ $30.48 Million |
0.262x | +112.87% |
| 2008-12-31 | CN¥768.11 Million ≈ $112.40 Million |
CN¥94.57 Million ≈ $13.84 Million |
0.123x | -46.98% |
| 2007-12-31 | CN¥750.11 Million ≈ $109.76 Million |
CN¥174.20 Million ≈ $25.49 Million |
0.232x | -36.48% |
| 2006-12-31 | CN¥436.05 Million ≈ $63.81 Million |
CN¥159.43 Million ≈ $23.33 Million |
0.366x | +72.33% |
| 2005-12-31 | CN¥411.93 Million ≈ $60.28 Million |
CN¥87.40 Million ≈ $12.79 Million |
0.212x | +65.59% |
| 2004-12-31 | CN¥371.08 Million ≈ $54.30 Million |
CN¥47.54 Million ≈ $6.96 Million |
0.128x | -60.01% |
| 2003-12-31 | CN¥328.83 Million ≈ $48.12 Million |
CN¥105.36 Million ≈ $15.42 Million |
0.320x | +3243.46% |
| 2002-12-31 | CN¥293.69 Million ≈ $42.98 Million |
CN¥2.81 Million ≈ $411.85K |
0.010x | +536.80% |
| 2001-12-31 | CN¥259.70 Million ≈ $38.00 Million |
CN¥-569.79K ≈ $-83.38K |
-0.002x | -108.50% |
| 2000-12-31 | CN¥274.23 Million ≈ $40.13 Million |
CN¥7.08 Million ≈ $1.04 Million |
0.026x | +138.74% |
| 1999-12-31 | CN¥307.93 Million ≈ $45.06 Million |
CN¥-20.52 Million ≈ $-3.00 Million |
-0.067x | -150.12% |
| 1998-12-31 | CN¥226.31 Million ≈ $33.12 Million |
CN¥30.10 Million ≈ $4.40 Million |
0.133x | -- |
About Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&… Read more